Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection

Detalles Bibliográficos
Autores principales: Fiorcari, Stefania, Atene, Claudio Giacinto, Maffei, Rossana, Debbia, Giulia, Potenza, Leonardo, Luppi, Mario, Marasca, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327720/
https://www.ncbi.nlm.nih.gov/pubmed/33691383
http://dx.doi.org/10.3324/haematol.2020.277392
_version_ 1783732152611897344
author Fiorcari, Stefania
Atene, Claudio Giacinto
Maffei, Rossana
Debbia, Giulia
Potenza, Leonardo
Luppi, Mario
Marasca, Roberto
author_facet Fiorcari, Stefania
Atene, Claudio Giacinto
Maffei, Rossana
Debbia, Giulia
Potenza, Leonardo
Luppi, Mario
Marasca, Roberto
author_sort Fiorcari, Stefania
collection PubMed
description
format Online
Article
Text
id pubmed-8327720
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-83277202021-08-11 Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection Fiorcari, Stefania Atene, Claudio Giacinto Maffei, Rossana Debbia, Giulia Potenza, Leonardo Luppi, Mario Marasca, Roberto Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-03-11 /pmc/articles/PMC8327720/ /pubmed/33691383 http://dx.doi.org/10.3324/haematol.2020.277392 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Fiorcari, Stefania
Atene, Claudio Giacinto
Maffei, Rossana
Debbia, Giulia
Potenza, Leonardo
Luppi, Mario
Marasca, Roberto
Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
title Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
title_full Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
title_fullStr Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
title_full_unstemmed Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
title_short Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
title_sort ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during covid-19 infection
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327720/
https://www.ncbi.nlm.nih.gov/pubmed/33691383
http://dx.doi.org/10.3324/haematol.2020.277392
work_keys_str_mv AT fiorcaristefania ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection
AT ateneclaudiogiacinto ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection
AT maffeirossana ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection
AT debbiagiulia ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection
AT potenzaleonardo ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection
AT luppimario ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection
AT marascaroberto ibrutinibinterfereswithinnateimmunityinchroniclymphocyticleukemiapatientsduringcovid19infection

Ejemplares similares